Equillium Stock (NASDAQ: EQ) stock price, news, charts, stock research, profile.
Open | $1.850 |
Close | $1.710 |
Volume / Avg. | 80.229K / 363.473K |
Day Range | 1.690 - 1.850 |
52 Wk Range | 0.450 - 3.250 |
Market Cap | $66.279M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 1.82% |
Days to Cover | 1.28 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Equillium (NASDAQ: EQ) through any online brokerage.
Other companies in Equillium’s space includes: Kezar Life Sciences (NASDAQ:KZR), Connect Biopharma Hldgs (NASDAQ:CNTB), CARISMA Therapeutics (NASDAQ:CARM), Eagle Pharmaceuticals (NASDAQ:EGRX) and Aligos Therapeutics (NASDAQ:ALGS).
The latest price target for Equillium (NASDAQ: EQ) was reported by HC Wainwright & Co. on Tuesday, April 2, 2024. The analyst firm set a price target for 5.00 expecting EQ to rise to within 12 months (a possible 165.96% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Equillium (NASDAQ: EQ) is $1.88 last updated April 26, 2024 at 9:25 AM EDT.
There are no upcoming dividends for Equillium.
Equillium’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Equillium.
Equillium is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.